886208-50-0

Basic information

• Product Name: Pyridazine, 3-chloro-6-phenyl-4-(4-pyridinyl)-
• CAS NO: 886208-50-0
• Molecular Formula: C15H10ClN3
• Molecular Weight: 267.717
• Mol File: 886208-50-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Pyridazine, 3-chloro-6-phenyl-4-(4-pyridinyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Pyridazine, 3-chloro-6-phenyl-4-(4-pyridinyl)-(886208-50-0)
• EPA Substance Registry System: Pyridazine, 3-chloro-6-phenyl-4-(4-pyridinyl)-(886208-50-0)

Safety Data

• Hazardous Substances Data: 886208-50-0(Hazardous Substances Data)

Upstream product

• 2051-95-8 succinylbenzene 
• 87769-64-0 4,5,-dihydro-6-phenyl-2-(phenylmethyl)-3(2H)-pyridazinone 
• 64942-62-7 3,4-dichloro-6-phenylpyridazine 
• 886208-45-3 4-chloro-2-(methoxymethyl)-6-phenylpyridazin-3(2H)-one 
• 1352920-48-9 C₂₂H₁₇N₃O 
• 1352920-46-7 C₁₇H₁₃ClN₂O 
• 89868-14-4 4-chloro-6-phenylpyridazin-3(2H)-one 
• 2166-31-6 6-phenylpyridazin-3(2H)-one 

Downstream Products

• 1357252-41-5 N-(cyclopropylmethyl)-6-phenyl-4-(pyridin-4-yl)pyridazin-3-amine hydrochloride 

Relevant articles and documents

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF ARTHRITIS

The invention relates to compounds, compositions, formulations and dosage forms comprising N-(Cyclopropylmethyl)-6-phenyl-4-(pyridin-4-yl)pyridazin-3- amine, or a pharmaceutically acceptable salt thereof, and methods for treating arthritis in a subject using such compounds, compositions, formulations and dosage forms.

COMPOSITIONS AND TREATMENTS USING PYRIDAZINE COMPOUNDS AND SECRETASES

The invention relates to compositions, conjugates and methods comprising pyridazine compounds and secretase inhibitors for modulation of cellular pathways (e.g., signal transduction pathways), for treatment or prevention of inflammatory diseases (e.g., Alzheimer's disease), for research, drug screening, and therapeutic applications.

COMPOSITIONS AND TREATMENTS FOR DEMYELINATING DISEASES AND PAIN DISORDERS

The invention relates to compositions and methods for treating patients with Demyelinating Diseases and Conditions including Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury and Stroke. The compositions and methods may also be used for Stroke Rehabilitation and the treatment of pain disorders including Neuropathic Pain and Chemokine-Induced Pain. The compositions comprise one or more pyridazine compounds having a pyridazinyl radical pendant with an aryl or substituted aryl, a heteroaryl or substituted heteroaryl.